Clinical Trials Browser

Phase EARLY_PHASE1 × Neuroblastoma × Gastrointestinal × Clear all

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

Phase EARLY_PHASE1 Unknown

CNSGastrointestinalSarcomaThoracic

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms